Forty years on, HIV still taking a toll on young people

Forty years on, HIV still taking a toll on young people

“Driving a fast car”; “getting the top three letters”; or “playing the lotto” – nearly 40 years from when HIV was first described, the virus is still a thing of euphemism and stigma. It’s also still infecting at least 4 000 people a day around the world, most of them young people, especially girls and young women. Ufrieda Ho reports.

Read More

INTERVIEW: Dr Thembisile Xulu on a year at the head of SANAC

INTERVIEW: Dr Thembisile Xulu on a year at the head of SANAC

On World AIDS Day, Dr Thembisile Xulu, CEO of the South African AIDS Council will share a podium with Deputy President David Mabuza for the country’s official commemoration event in Limpopo. Bienne Huisman spoke to her about how she settled into the CEO role and what keeps her busy.

Read More

Are two medicines instead of three the future of HIV treatment?

Are two medicines instead of three the future of HIV treatment?

One of the biggest breakthroughs in HIV treatment in the 1990s came when three different antiretrovirals were used together, suppressing viral replication in multiple ways and preventing the development of drug resistance. Now, trials are showing that certain combinations of just two antiretrovirals might be as good as three, potentially bringing an end to a quarter of a century of triple therapy dominance. Elri Voigt reports.

Read More

Opinion: We should make it much easier for people to start and stay on HIV treatment

Opinion: We should make it much easier for people to start and stay on HIV treatment

The top priority in our HIV programme should be to make it as easy as possible for people to start and stay on treatment. Yet, as a number of provincial reports released this year by community monitoring group Ritshidze have shown, there are many healthcare system factors that work directly against this objective. Spotlight editor Marcus Low considers some of the potential solutions.

Read More

OPINION: How to capitalise on the opportunity of COVID-19 vaccination sites

OPINION: How to capitalise on the opportunity of COVID-19 vaccination sites

To combat COVID-19, our country has been able to move millions of people through vaccination sites each month, creating a potential ‘one-stop shop’ for vital health check-ups. In this, healthcare workers have an unprecedented opportunity to reach people they may not otherwise have access to, such as those living with HIV, writes Dhirisha Naidoo.

Read More

Opinion: Funding must be allocated to treat drivers of HIV

Opinion: Funding must be allocated to treat drivers of HIV

If South Africa wants to strengthen the prevention arm of its HIV programme, which it definitely should, providing comprehensive sex education in schools and training teachers to deliver this curriculum will be vital. It is important that the HIV/AIDS Life Skills Grant, as one of the key pieces of a broader HIV prevention strategy, be supported and strengthened, argue Mbali Baduza and Julia Chaskalson.

Read More

Modest improvement at dysfunctional Gauteng clinics, report finds

Modest improvement at dysfunctional Gauteng clinics, report finds

Although a new community healthcare monitoring report notes some improvement in filling vacancies at Gauteng clinics, concerns remain over staff shortages and the impact this has on providing quality care, especially to people living with HIV. Thabo Molelekwa reports.

Read More

In-depth: New licenses could spark manufacture of COVID-19 pills in Africa

In-depth: New licenses could spark manufacture of COVID-19 pills in Africa

Pharmaceutical companies Merck and Pfizer recently announced early results from clinical trials showing that two new antiviral medicines are highly effective in reducing COVID-19 deaths and hospitalisation. The Medicines Patent Pool then announced licensing deals with both companies that will allow for generic versions of the two drugs to be produced. Catherine Tomlinson unpacks the licenses and asks whether generic versions of these pills might now be made in Africa.

Read More

Interview: Prof Lynette Denny reflects on an extraordinary life of service

Interview: Prof Lynette Denny reflects on an extraordinary life of service

Professor Lynette Denny of the University of Cape Town recently received the Order of the Baobab, the country’s highest accolade for citizen excellence. Bienne Huisman spoke to her about her ground-breaking research in cervical cancer prevention, her own ongoing struggle with cancer, and the enrichment she has found in being of service.

Read More

Circumcision reducing HIV infections but COVID-19 caused setbacks

Circumcision reducing HIV infections but COVID-19 caused setbacks

A UNAIDS report published earlier this year estimates that just under 4.5 million men and boys accessed voluntary male medical circumcision (VMMC) services in South Africa by the end of 2019 with 47% of these having been performed from 2016 to 2019. Thabo Molelekwa reports on the impact COVID-19 has had on VMMCs and the challenges related to resuming this service in the country.

Read More

HPV: What is happening with SA’s other relatively new vaccine programme?

HPV: What is happening with SA’s other relatively new vaccine programme?

In 2014, South Africa launched an HPV vaccination campaign targeting 9-year-old public school learners in Grade 4. It involves delivering two doses of vaccine six months apart. Laura Owings asks how the campaign is going and what recent real-world HPV vaccine effectiveness data from the United Kingdom might mean for South Africa.

Read More

In-depth: Is government ready to invest in mental health?

In-depth: Is government ready to invest in mental health?

Mental health does not have its own ring-fenced budget and given huge inefficiencies in our mental health spending, we need to be strategic on where and how we spend the little we have. Alicestine October unpacks what a new government-commissioned mental health investment case framework can mean for access to equitable and quality mental health services in the country. 

Read More